Word

C

Status

Dead

Status Code

602

Status Date

Tuesday, July 6, 2010

Serial Number

77513015

Mark Type

3000

Filing Date

Tuesday, July 1, 2008

Abandoned Date

Friday, June 4, 2010

Trademark Owner History

Ceres Nanosciences, LLLP

Classifications

1 Nucleic acids, biotechnology formed genes, enzymes, and protein arrays for industrial, agricultural, and scientific research use in the fields of biotechnology, nanotechnology and proteomics

5 Pharmaceutical preparations for scientific laboratory research in the fields of biotechnology, nanotechnology and proteomics, namely, pharmaceutical preparations for use in the collection of tissue samples and fluid samples, pharmaceutical preparations for use in growth hormone screening, cancer screening, anti-doping screening, biomedical screening, pharmaceutical preparations for use in protein analysis, and biomedical analysis, pharmaceutical preparations for diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons and animals

9 Measuring apparatus for measuring proteins, DNA, RNA, and isoforms of the same, namely, nano-particles for use as measuring apparatus for scientific research in laboratories

10 Medical measuring apparatus for measuring proteins, DNA, RNA, and isoforms of the same, namely, nano-particles for use as medical measuring apparatus for medical research in laboratories and medical analysis services using nano-particles and biomarker analysis for collection of tissue samples and fluid samples, growth hormone screening, cancer screening, anti-doping screening, biomedical screening, protein analysis, and biomedical analysis, and diagnosis and treatment of cancer, infectious diseases, genetic inherited diseases, and blood disorders, in persons, animals and materials

42 Scientific and technological research services in the field of biotechnology, nanotechnology and proteomics, as it relates to collection of tissue samples and fluid samples, growth hormone screening, cancer screening, anti-doping screening, biomedical screening, protein analysis, and biomedical analysis, and diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons, animals, and materials; scientific and technological research services in the field of biotechnology, nanotechnology and proteomics using fluids, earths, and other materials or substances, namely, nucleic acids, genes, enzymes, and proteins, for scientific, pharmaceutical, industrial, agricultural, and scientific research use

44 Medical diagnostic testing in the field of nanotechnology, biotechnology and proteomics, namely, using biomarker analysis for collection of tissue samples and fluid samples, growth hormone screening, cancer screening, anti-doping screening, biomedical screening, protein analysis, and biomedical analysis, and diagnosis and treatment of cancer, infectious diseases, genetic inherited disease, and blood disorders, in persons, animals, and materials

Color is not claimed as a feature of the mark.
The mark consists of seventeen shaded circles forming the letter "C".
CERES

Trademark Events

Jul 7, 2010

Abandonment Notice Mailed - Failure To Respond

Jul 6, 2010

Abandonment - Failure To Respond Or Late Response

Dec 3, 2009

Notification Of Non-Final Action E-Mailed

Dec 3, 2009

Non-Final Action E-Mailed

Dec 3, 2009

Non-Final Action Written

Oct 29, 2009

Previous Allowance Count Withdrawn

Oct 23, 2009

Withdrawn From Pub - Og Review Query

Oct 13, 2009

Law Office Publication Review Completed

Oct 13, 2009

Assigned To Lie

Sep 27, 2009

Approved For Pub - Principal Register

Sep 4, 2009

Teas/Email Correspondence Entered

Sep 4, 2009

Correspondence Received In Law Office

Sep 4, 2009

Teas Response To Office Action Received

May 15, 2009

Assigned To Examiner

Apr 23, 2009

Notification Of Non-Final Action E-Mailed

Apr 23, 2009

Non-Final Action E-Mailed

Apr 23, 2009

Non-Final Action Written

Apr 7, 2009

Teas/Email Correspondence Entered

Apr 6, 2009

Correspondence Received In Law Office

Apr 6, 2009

Teas Response To Office Action Received

Oct 9, 2008

Notification Of Non-Final Action E-Mailed

Oct 9, 2008

Non-Final Action E-Mailed

Oct 9, 2008

Non-Final Action Written

Oct 6, 2008

Assigned To Examiner

Jul 8, 2008

Notice Of Design Search Code And Pseudo Mark Mailed

Jul 7, 2008

New Application Entered In Tram